LogicBio Therapeutics, Inc.
Alexion Pharmaceuticals, Inc. is dedicated to transforming the lives of people affected by rare diseases through continuous innovation and meaningful value creation. As part of AstraZeneca, they focus on developing breakthrough therapies, advancing science, and improving health equity for the rare disease community worldwide.
Industries
Nr. of Employees
medium (51-250)
LogicBio Therapeutics, Inc.
Patents
Services
Design and conduct of clinical trials for rare diseases with integrated patient engagement, patient-focused metrics and global trial execution.
Case-by-case managed access service for patients who have exhausted treatment options and cannot join clinical trials, assessed against clinical, regulatory and supply criteria.
Partnership intake, evaluation and collaboration support for preclinical translation, target validation, biomarker development and technology advancement.
Administrative and scientific support pathways for investigator-sponsored research and externally sponsored collaborations, including submission portals and investigator guides.
Grantmaking and charitable funding for medical education, patient advocacy, local needs and emergency response through a centralized foundation program.
Design and conduct of clinical trials for rare diseases with integrated patient engagement, patient-focused metrics and global trial execution.
Case-by-case managed access service for patients who have exhausted treatment options and cannot join clinical trials, assessed against clinical, regulatory and supply criteria.
Partnership intake, evaluation and collaboration support for preclinical translation, target validation, biomarker development and technology advancement.
Administrative and scientific support pathways for investigator-sponsored research and externally sponsored collaborations, including submission portals and investigator guides.
Grantmaking and charitable funding for medical education, patient advocacy, local needs and emergency response through a centralized foundation program.
Expertise Areas
- Rare disease research and development
- Clinical trial management and patient-centric design
- Genomics and diagnostic development
- Data science, AI and digital health
Key Technologies
- Artificial intelligence / machine learning
- Next-generation sequencing (NGS)
- Digital health platforms
- Data analytics and web analytics
News & Updates
Coverage of Rare Disease Day highlighting Alexion’s efforts to impact the rare disease community.
Highlighting the global impact of rare diseases and Alexion’s commitment.
Features on Alexion’s research and development efforts in rare diseases.
Profiles of key leaders in Alexion’s R&D team.
Discussion on Alexion’s initiatives to improve health equity.
An article on Alexion’s efforts to address unmet needs in amyloidosis.
Coverage of Rare Disease Day highlighting Alexion’s efforts to impact the rare disease community.
Highlighting the global impact of rare diseases and Alexion’s commitment.
Features on Alexion’s research and development efforts in rare diseases.
Profiles of key leaders in Alexion’s R&D team.
Discussion on Alexion’s initiatives to improve health equity.
An article on Alexion’s efforts to address unmet needs in amyloidosis.